Updates from #ASCO23: mRCC & the CONTACT03 Trial

This week’s episode is part 3 of 5 of a joint mini-series with The Fellow On Call. We will be recapping the current treatment of metastatic renal cell carcinoma (mRCC) and covering an oral abstract from the ASCO 2023 annual meeting, the CONTACT03 Trial. We also cover subgroup analysis interpretation.

Episode metadata supplied by the publisher feed · Published Jun 19, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Updates from #ASCO23: mRCC & the CONTACT03 Trial

0:00 15:57

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Two Onc Docs?

This episode is 15 minutes long.

When was this Two Onc Docs episode published?

This episode was published on June 19, 2023.

Can I download this Two Onc Docs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!